公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease | Lee, Chia-Chia; Chang, Ching-Pang; CHUN-JUNG LIN ; Lai, Hsing-Lin; Kao, Yu-Han; Cheng, Sin-Jhong; Chen, Hui-Mei; Liao, Yu-Ping; Faivre, Emilie; Buee, Luc; Blum, David; Fang, J.-M. ; HUI-MEI CHEN | Molecular Neurobiology | 35 | 35 | |
2024 | Administration mode matters for 5‐fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus | Chao, Chih‐Jia; Gardner, Iain; CHUN-JUNG LIN ; KUN-HUEI YEH ; Lu, Wan‐Chen; Abduljalil, Khaled; YUNN-FANG HO | British Journal of Clinical Pharmacology | | | |
2021 | Amelioration of lipopolysaccharide-induced memory impairment in equilibrative nucleoside transporter-2 knockout mice is accompanied by the changes in glutamatergic pathways | Wu, Kuo-Chen; Lee, Chih-Yu; Chern, Yijuang; CHUN-JUNG LIN | Brain, Behavior, and Immunity | 6 | 5 | |
2024 | Anticonvulsant effect of equilibrative nucleoside transporters 1 inhibitor in a mouse model of Dravet syndrome | Ho, Shih-Yin; I-CHUN CHEN ; WEN-CHE TSAI ; Chang, Kai-Chieh; CHUN-JUNG LIN ; Chern, Yijuang; HORNG-HUEI LIOU | Hippocampus | | | |
2022 | The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities | Atsunori Kaibara; Ao Peng; Rujia Xie; YUNN-FANG HO ; CHUN-JUNG LIN ; Lai-San Tham; Surulivelrajan Mallayasamy; Korbtham Sathirakul; Yoke-Lin Lo; Manh Hung Tran; Van Toi Pham; Akhmad Kharis Nugroho; Khin Myo Oo; Bimal Kunwar; Uthpali Mannapperuma; Kimheang Ya; Muhammad Usman; Long Chiau Ming; Kyungsoo Park | CPT: Pharmacometrics and Systems Pharmacology | 1 | 1 | |
2009 | Aspect-ratio-dependent ultra-low reflection and luminescence of dry-etched Si nanopillars on Si substrate | Pai, Y.-H.; Meng, F.-S.; Lin, C.-J.; Kuo, H.-C.; Hsu, S.-H.; Chang, Y.-C.; GONG-RU LIN ; Lin, Chun-Jung | Nanotechnology | 18 | 17 | |
2008 | Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy | CHUN-JUNG LIN ; Yen M.-F.; Hu O.Y.-P.; Lin M.-S.; Hsiong C.-H.; Hung, Chin-Chuan; HORNG-HUEI LIOU | Pharmacotherapy | 7 | 6 | |
2015 | Biotransformed product, genistein 7-O-phosphate, enhances the oral bioavailability of genistein | Wang, Shang-Ta; Fang, Ting-Fang; Hsu, Chen; Chen, Chia-Hao; CHUN-JUNG LIN ; NAN-WEI SU | Journal of Functional Foods | 17 | 18 | |
2010 | Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents | CHUN-JUNG LIN ; Tai Y.; Huang M.-T.; Tsai Y.-F.; Hsu H.-J.; KAI-YUAN TZEN ; HORNG-HUEI LIOU | Journal of Neurochemistry | 97 | 80 | |
2009 | Change in P-glycoprotein and caveolin protein expression in brain striatum capillaries in New Zealand Obese mice with type 2 diabetes | Wu, Kuo-Chen; Pan H.-J.; HSIANG-SHU YIN ; MEI-RU CHEN ; SHAO-CHUN LU ; CHUN-JUNG LIN | Life Sciences | 29 | 24 | |
2021 | Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis | Lai, Po Hsuan; Wang, Ting Hsuan; Zhang, Nai You; Wu, Kuo Chen; JANE CHUNG-CHEN YAO ; CHUN-JUNG LIN | Journal of Neuroinflammation | 12 | 11 | |
2008 | Characterization of Si nanorods by spectroscopic ellipsometry with efficient theoretical modeling | Hsu, S.-H.; Liu, E.-S.; Chang, Y.-C.; Hilfiker, J.N.; Kim, Y.D.; Kim, T.J.; Lin, C.-J.; Lin, G.-R.; GONG-RU LIN ; Lin, Chun-Jung | Physica Status Solidi (A) Applications and Materials Science | 33 | 31 | |
1999 | Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: Interaction of ACE inhibitors with high-affinity H+/peptide symporter | CHUN-JUNG LIN | Pharmaceutical Research | 32 | 31 | |
2005 | Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response | Hung, Chin-Chuan; Tai J.J.; CHUN-JUNG LIN ; MING-JEN LEE ; HORNG-HUEI LIOU | Pharmacogenomics | 118 | 102 | |
2023 | The Critical Role of Equilibrative Nucleoside Transporter-2 in Modulating Cerebral Damage and Vascular Dysfunction in Mice with Brain Ischemia-Reperfusion | Chiang, Hui-Ling; Wu, Kuo-Chen; Chen, You-Yin; Ho, Chin-Jui; Wang, Han-Lin; Fu, Yu-Hua; Chen, Wen-Yu; CHUN-JUNG LIN | Pharmaceutical research | | | |
2017 | The critical role of Nramp1 in degrading α-synuclein oligomers in microglia under iron overload condition | Wu K.-C.; HORNG-HUEI LIOU ; Kao Y.-H.; Lee C.-Y.; CHUN-JUNG LIN | Neurobiology of Disease | 12 | 11 | |
2010 | CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection | JYH-CHIN YANG ; CHUN-JUNG LIN | Expert Opinion on Drug Metabolism and Toxicology | 48 | 42 | |
2015 | Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice | CHUN-JUNG LIN | Journal of Cerebral Blood Flow and Metabolism | 30 | 22 | |
2023 | Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington's disease | Chen, Ching-Ya; Chou, Fang-Yi; Chang, Ya-Gin; Ho, Chin-Jui; Wu, Kuo-Chen; Hsu, Chia-Lin; Chern, Yijuang; CHUN-JUNG LIN | Neurobiology of disease | 1 | | |
2020 | Deletion of equilibrative nucleoside transporter-2 protects against lipopolysaccharide-induced neuroinflammation and blood-brain barrier dysfunction in mice | Wu K.-C.; Lee C.-Y.; Chou F.-Y.; Chern Y.; CHUN-JUNG LIN | Brain, Behavior, and Immunity | 22 | 20 | |